Ovariectomy (Oophorectomy)

Subscribe to Selected New Research on Ovariectomy

3562 relevant articles (140 outcomes, 315 trials/studies) found for this Therapy

Description: The surgical removal of one or both ovaries.

Also Known As:

Oophorectomy; Bilateral Ovariectomy; Bilateral Ovariectomies; Castrations, Female; Female Castration; Female Castrations; Oophorectomies; Ovariectomies; Ovariectomies, Bilateral; Ovariectomy, Bilateral; Castration, Female

Relationship Network

Therapy Context: Research Results

Operative Surgical Procedures: 4

Endocrine Surgical Procedures: 1

Castration: 2025

Ovariectomy: 3562

Urogenital Surgical Procedures

Castration: 2025

Ovariectomy: 3562

Gynecologic Surgical Procedures: 689

Ovariectomy: 3562

Experts

1.	Love, Richard R: 7 articles (01/2008 - 05/2002)
2.	Lynch, Henry T: 5 articles (07/2006 - 12/2003)
3.	Isaacs, Claudine: 4 articles (03/2008 - 11/2003)
4.	Daly, Mary B: 4 articles (03/2008 - 11/2003)
5.	Narod, Steven A: 4 articles (07/2006 - 05/2005)
6.	Evans, D Gareth: 3 articles (03/2008 - 10/2002)
7.	Offit, Kenneth: 3 articles (03/2008 - 05/2003)
8.	Rebbeck, Timothy R: 3 articles (03/2008 - 11/2005)
9.	Neuhausen, Susan L: 3 articles (03/2008 - 10/2005)
10.	Brekelmans, Cecile T M: 3 articles (03/2006 - 05/2003)

Related Diseases

1.	Neoplasms (Cancer) 01/01/1994 - "The remission rates of tumors found after treatment with ICI, ON, the combination and ovariectomy (complete and partial remission) were 15%, 46%, 71% and 100% respectively" 07/01/2004 - "Radical interventions, such as extensive tumor debulking and oophorectomy for hormonal control, although effective in many cases, are not always possible or desirable and carry significant morbidity" 10/01/2003 - "We report 2 patients with metastatic ovarian tumors of gastric origin who underwent oophorectomy with paraaortic and intrapelvic lymph node dissection, and showed a relatively good outcome" 05/15/1997 - "CONCLUSIONS: On the basis of a range of estimates of the incidence of cancer, prognosis, and efficacy of prophylactic surgery, our model suggests that prophylactic mastectomy provides substantial gains in life expectancy and prophylactic oophorectomy more limited gains for young women with BRCA1 or BRCA2 mutations." 01/01/1998 - "The mainstay of treatment is debulking surgery consisting of total abdominal hysterectomy, bilateral salpingo-oophorectomy and extirpation of tumor masses" Get all the results and reference details, order at left...
2.	Breast Neoplasms (Breast Cancer) 10/20/2005 - "RESULTS: A previous history of oophorectomy was associated with a significant reduction in breast cancer risk of 56% for BRCA1 carriers (OR = 0.44; 95% CI, 0.29 to 0.66) and of 46% for BRCA2 carriers (OR = 0.57; 95% CI, 0.28 to 1.15)" 10/01/2003 - "BACKGROUND: Because of the uncertain efficacy of breast cancer screening in women at increased risk of developing breast cancer, bilateral prophylactic oophorectomy and mastectomy are considered management options for high-risk women" 09/01/1999 - "RESULTS: We found a statistically significant reduction in breast cancer risk after bilateral prophylactic oophorectomy, with an adjusted hazard ratio (HR) of 0.53 (95% confidence interval [CI] = 0.33-0.84)" 11/01/2005 - "Bilateral salpingo-oophorectomy is effective in reducing the risk of developing breast cancer in both BRCA-1 and BRCA-2 mutation carriers by 50%" 11/10/2004 - "The purpose of our study was to review the evidence for the efficacy of surveillance for early detection, bilateral prophylactic mastectomy, prophylactic oophorectomy and chemoprevention in preventing breast cancer and improving survival of BRCA1 or BRCA2 carriers" Get all the results and reference details, order at left...
3.	Ovarian Neoplasms (Ovarian Cancer) 11/01/2000 - "Because most options for ovarian cancer prevention are not highly efficacious, many high-risk women consider the option of bilateral prophylactic oophorectomy (BPO), in the hope that removal of healthy ovarian tissue will reduce their risk of developing invasive malignancy" 11/01/1991 - "This article presents the background, rationale, and structure of the Yale Early Detection Program for ovarian cancer, whose goals are to identify the best techniques for diagnosing ovarian cancer in an early stage, to determine the frequency with which such tests should be employed, to assess false-positive results, and to identify women who might benefit from prophylactic oophorectomies." 01/01/2005 - "As in ovarian neoplasms, the mainstay of treatment is represented by debulking surgery consisting of total abdominal hysterectomy, bilateral salpingo-oophorectomy, random biopsies, peritoneal washing and excision of all the abdominal tumour masses" 12/01/2003 - "With continued improvement in genetic screening, the literature regarding prevention of ovarian cancer appears to be moving beyond the appropriateness of prophylactic oophorectomy to a discussion of the technical aspects of the procedure" 10/01/2003 - "BACKGROUND: The aim of this study was to describe the feasibility, associated morbidity, and efficacy of radical oophorectomy with primary stapled colorectal anastomosis among patients with locally advanced ovarian cancer with contiguous extension to or encasement of the reproductive organs, pelvic peritoneum, cul-de-sac, and sigmoid colon" Get all the results and reference details, order at left...
4.	Osteoporosis 01/01/2007 - "We investigated whether treatments with beta-blockers or other administrations that have similar actions to beta-blockers, such as Chinese herbs or needling, were effective in treating osteoporosis induced by ovariectomy (OVX)" 01/01/2004 - "The flavonoid extract from Epimedium sagittatum (FES) has been found by us to be effective in preventing osteoporosis induced by ovariectomy in rats" 10/01/1999 - "OBJECTIVE: To investigate the efficacy of Chinese recipe of replenishing Kidney and activating blood circulation (RKABC) in female rats with osteoporosis induced by ovariectomy" 10/01/1999 - "Efficacy of Chinese recipes of replenishing kidney and activating blood circulation in female rats with osteoporosis induced by ovariectomy]" 06/01/2007 - "In order to study the effect of ovariectomy on the capacity of rat MSCs' differentiation into adipocytes, we established the animal models of osteoporosis by performing ovariectomy on the 3-months-old and 6-month-old female SD rats" Get all the results and reference details, order at left...
5.	Neoplasm Metastasis (Metastasis) 03/01/1975 - "The highest incidence of remission following the operation occurred in those women with only osseous metastases (83%) or with previous remission to both therapeutic oophorectomy and androgen administration (86%)" 11/01/1975 - "After ovariectomy the lung metastases cleared almost completely" 03/01/1975 - "No patient with primary central nervous system metastases, only one of ten with hepatic metastases, and none who had failed to respond to both oophorectomy and exogenous androgen administration experienced remission after hypophysectomy" 10/01/1972 - "Studies show that ovariectomy does not increase survival time, but lengthens the interval before metastases appear, although the evolution is then more rapid" 07/01/2008 - "Bilateral oophorectomy was considered when ovarian metastases were histologically diagnosed." Get all the results and reference details, order at left...
498 Diseases and 3562 more articles analyzed in the Research Interface, order at left...

Related Drugs and Biologics

1.	Estrogens (Estrogen)
2.	Tamoxifen
3.	Hormones
4.	Gonadotropin-Releasing Hormone (GnRH)
5.	Testosterone (Sustanon)
6.	Estradiol (Estrace)
7.	Goserelin (Zoladex)
8.	Progesterone
9.	Steroids
10.	salmon calcitonin (Calcimar)
555 Drugs and Important Bio-Agents and 1218 more articles analyzed in the Research Interface, order at left...

Related Therapies and Procedures

1.	Hysterectomy
2.	Mastectomy (Mammectomy)
3.	Drug Therapy (Chemotherapy)
4.	Hypophysectomy
5.	Lymph Node Excision (Lymph Node Dissection)
102 Therapies and Procedures and 1355 more articles analyzed in the Research Interface, order at left...

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License details >>

Price:

$490.00 access via web interface, 1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m", 1 year subscription

Proceed to Checkout >>